Freeman Technology highlights relevance of the FT4 for DPI characterisation
Respiratory Drug Delivery (RDD) 2010, 25 - 29 April 2010, Florida, US
Dynamic powder characterization with the FT4 directly quantifies powder flowability and the response of a formulation to air, a critical property for successful DPI development. To ensure efficient drug delivery a DPI formulation/device combination must be engineered to achieve aerosolisation of the dose to a respirable size during use.
Research at the University of Bath has shown a robust correlation between FPD and aerated energy, a measure of how the flowability of the powder changes with the amount of air flowing through it. This makes the FT4 an extremely useful tool for the development of DPI formulations, which are required to disperse easily, with more consistent and less patient dependent performance.
The FT4 combines dynamic testing methodologies with shear and bulk property measurement, to provide comprehensive, process relevant powder characterisation. Precision engineering in combination with well-defined, automated test procedures deliver exceptional reproducibility and sensitivity. With application know-how that has been gained from 10 years working with industry, Freeman Technology also provides extensive powder processing expertise alongside the FT4 Powder Rheometer.
You may also like
Manufacturing
Cellevate achieves ISO 9001:2015 certification alongside GMP production processes in new cleanroom
Read moreThe certification caps off a strong 2025 for the company, which now has a scalable foundation for expanding manufacturing capacity and implementing GMP-ready processes for commercial volumes
Trending Articles
You may also like
Manufacturing
Cellevate achieves ISO 9001:2015 certification alongside GMP production processes in new cleanroom
The certification caps off a strong 2025 for the company, which now has a scalable foundation for expanding manufacturing capacity and implementing GMP-ready processes for commercial volumes
Manufacturing
LYOVAC® ECO Mode: making pharmaceutical freeze-drying leaner and greener
Following the recent announcement that GEA Lyophil has received third-party certification for the energy-saving credentials of its innovative algorithm for freeze-drying applications, Dr Kevin Robinson caught up with Senior Director of Lyophilization Technology Management, Thomas Beutler, to find out more
Regulatory
Grifols gets nod from European Medicines Agency for entire value chain of Grifols Egypt
The institution's certification endorses the entire plasma value chain under the highest European standards and opens the door for Egypt to, once domestic needs are met, export to other markets including Europe
Regulatory
Regulating innovation: a new focus on digital mental health technologies (DMHTs)
IMed Consultancy’s Benjamin Austin provides a clear understanding of how digital mental health technologies are innovating care and describes the evolving regulatory frameworks that ensure their safety and effectiveness
Regulatory
ten23 health QC lab to support commercial product testing for US customer following FDA approvals
This pivotal regulatory milestone enables FDA-compliant release and stability testing for injectable drug products throughout the clinical and commercial phases, in addition to manufacturing the commercial product